Namyangju-si, South Korea

Hee Chung Kwon


Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Seoul, KR (2012)
  • Namyangju-si, KR (2015 - 2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Hee Chung Kwon

Introduction

Hee Chung Kwon, an innovative inventor based in Namyangju-si, South Korea, has made significant strides in the field of cancer research. With three patents to his name, Kwon's work focuses on the development of pharmaceutical compositions that target specific gene expressions, aiming to enhance treatment outcomes for cancer patients.

Latest Patents

Kwon's latest patents include a groundbreaking cancer-treating pharmaceutical composition that inhibits the expression of the CCND3 or PAK2 gene. This composition contains a nucleotide such as miR-4779, which is recognized for its potential in preventing or treating cancer. By screening substances that inhibit the expression of these particular genes, researchers can identify effective candidate substances for cancer treatment.

Another significant patent involves a composition comprising miRNA that enhances radiation sensitivity. Kwon has developed methods using miR-499b-5p to improve radiation sensitivity, thus providing new approaches for treating radiation-resistant cancers.

Career Highlights

Hee Chung Kwon is affiliated with the Korea Institute of Radiological and Medical Sciences, where he contributes to pioneering research in cancer therapeutics. His work has led to considerable advancements in the understanding and treatment of various types of cancer, particularly focusing on gene expression modulation.

Collaborations

Kwon's innovative endeavors are supported by collaboration with esteemed colleagues, including Jie Young Song and Hyun Jung Baek. Their combined expertise fosters a dynamic research environment devoted to addressing critical challenges in cancer treatment and improving patient outcomes.

Conclusion

Through his impressive portfolio of patents and collaborations, Hee Chung Kwon is paving the way for novel cancer treatments that harness the power of gene expression modulation. His research represents a crucial step forward in the ongoing battle against cancer, highlighting the importance of innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…